ITERATIVE PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF HIV PROTEASE INHIBITORS

被引：0

作者：

KALISH, V ^{[1
]}

KALDOR, S ^{[1
]}

SHETTY, B ^{[1
]}

TATLOCK, J ^{[1
]}

DAVIES, J ^{[1
]}

HAMMOND, M ^{[1
]}

DRESSMAN, B ^{[1
]}

FRITZ, J ^{[1
]}

APPELT, K ^{[1
]}

REICH, S ^{[1
]}

MUSICK, L ^{[1
]}

WU, BW ^{[1
]}

SU, K ^{[1
]}

机构：

[1] ELI LILLY & CO,INDIANAPOLIS,IN 46285

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 1995年 / 30卷

关键词：

HIV PROTEASE INHIBITORS; STRUCTURE-BASED DRUG DESIGN; AG1343; AIDS;

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

下载

页码：S201 / S214

页数：14

共 50 条

[41] Structure-based design: Synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors
Ghosh, AK
Swanson, LM
Cho, HN
Leshchenko, S
Hussain, KA
Kay, S
Walters, DE
Koh, Y
Mitsuya, H
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (10) : 3576 - 3585
[42] STRUCTURE-BASED DRUG DESIGN WITH HIV INTEGRASE.
Greenwald, J.
Vix, O.
Farnet, C.
Bushman, P.
Choe, S.
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C204 - C204
[43] Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors
Namoto, Kenji
Sirockin, Finton
Sellner, Holger
Wiesmann, Christian
Villard, Frederic
Moreau, Robert J.
Valeur, Eric
Paulding, Stephanie C.
Schleeger, Simone
Schipp, Kathrin
Loup, Joachim
Andrews, Lori
Swale, Ryann
Robinson, Michael
Farady, Christopher J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (05) : 906 - 909
[44] STRUCTURE-BASED DESIGN OF HIV-1 PROTEASE INHIBITORS EMPLOYING A SIMPLE METHOD FOR PREDICTING ACTIVITY
HOLLOWAY, MK
WAI, JM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 87 - COMP
[45] Structure-based design and solid phase synthesis of cysteine protease inhibitors for parasitic diseases.
Gong, BQ
Chen, XW
Cheng, MS
Li, RS
Kenyon, GL
Cohen, FE
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 39 - MEDI
[46] STRUCTURE OF A NONPEPTIDE INHIBITOR COMPLEXED WITH HIV-1 PROTEASE - DEVELOPING A CYCLE OF STRUCTURE-BASED DRUG DESIGN
RUTENBER, E
FAUMAN, EB
KEENAN, RJ
FONG, S
FURTH, PS
DEMONTELLANO, PRO
MENG, E
KUNTZ, ID
DECAMP, DL
SALTO, R
ROSE, JR
CRAIK, CS
STROUD, RM
JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (21) : 15343 - 15346
[47] THE DESIGN AND SYNTHESIS OF HIV PROTEASE INHIBITORS
YOUNG, SD
ANDERSON, PS
DARKE, PL
DAVIS, LJ
DESOLMS, SJ
DIXON, RAF
EMINI, E
GAFFIN, N
GUARE, JP
HUFF, JR
ROBERTSON, G
SANDERS, WM
SIGAL, IS
SCHLEIF, W
VACCA, JP
WIGGINS, JM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 84 - MEDI
[48] Structure-based design of protease inhibitors as therapeutics: Some examples.
Reich, SH
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U595 - U595
[49] A Novel Strategy for the Structure-based Drug Design of Heat Shock Protein 90 Inhibitors
Chen, Omix Yu-Chian
Chen, Guan-Wen
Chen, WinstonYu-Chen
2008 IEEE INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS, VOLS 1-8, 2008, : 1199 - 1206
[50] Latest developments in crystallography and structure-based design of protein kinase inhibitors as drug candidates
Williams, DH
Mitchell, T
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (05) : 567 - 573

← 1 2 3 4 5 →